Co-Authors
This is a "connection" page, showing publications co-authored by BO PENG and BO PENG.
Connection Strength
2.403
-
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20; 507(7492):315-22.
Score: 0.486
-
Simulating sequences of the human genome with rare variants. Hum Hered. 2010; 70(4):287-91.
Score: 0.393
-
Forward-time simulation of realistic samples for genome-wide association studies. BMC Bioinformatics. 2010 Sep 01; 11:442.
Score: 0.383
-
Simulating gene-environment interactions in complex human diseases. Genome Med. 2010 Mar 23; 2(3):21.
Score: 0.372
-
Simulations provide support for the common disease-common variant hypothesis. Genetics. 2007 Feb; 175(2):763-76.
Score: 0.296
-
simuPOP: a forward-time population genetics simulation environment. Bioinformatics. 2005 Sep 15; 21(18):3686-7.
Score: 0.269
-
Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study. Cancer Med. 2018 08; 7(8):4104-4114.
Score: 0.041
-
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum. 2013 Dec; 65(12):3239-47.
Score: 0.030
-
Propagation of obesity across generations: the roles of differential realized fertility and assortative mating by body mass index. Hum Hered. 2013; 75(2-4):204-12.
Score: 0.030
-
Screen for Footprints of Selection during Domestication/Captive Breeding of Atlantic Salmon. Comp Funct Genomics. 2012; 2012:628204.
Score: 0.028
-
A modified forward multiple regression in high-density genome-wide association studies for complex traits. Genet Epidemiol. 2009 Sep; 33(6):518-25.
Score: 0.022
-
Detection of disease-associated deletions in case-control studies using SNP genotypes with application to rheumatoid arthritis. Hum Genet. 2009 Aug; 126(2):303-15.
Score: 0.022
-
Estimating the growth rates of primary lung tumours from samples with missing measurements. Stat Med. 2005 Apr 15; 24(7):1117-34.
Score: 0.016
-
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer. 2004 May 01; 100(9):1814-22.
Score: 0.015